NYSE: RADRite Aid Corp Stock
$2.55-0.13 (-4.85%)
Updated Mar 20, 2023
RAD Price
$2.55
Fair Value Price
N/A
Market Cap
$144.13M
52 Week Low
$2.43
52 Week High
$11.61
P/E
-0.15x
P/B
-0.36x
P/S
0.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$24.06B
Earnings
-$897.69M
Gross Margin
19.9%
Operating Margin
-2.85%
Profit Margin
-3.7%
Debt to Equity
-21.34
Operating Cash Flow
$24M
Beta
1.17
Next Earnings
Apr 12, 2023
Ex-Dividend
N/A
Next Dividend
N/A
RAD Overview
Rite Aid Corporation offers healthcares services. Its Retail Pharmacy segment sells brand and generic prescription drugs and various other pharmacy services, as well as health and beauty aids, personal care products, and seasonal merchandise. The Pharmacy Services segment provides a range of pharmacy benefit services through its Elixir subsidiary. Elixir is a pharmacy services provider offering pharmacy benefit management services, Medicare-approved prescription drug plans, mail and specialty pharmacy solutions, and prescription discount programs. Rite Aid was founded in 1962 and is headquartered in Camp Hill, PA.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how RAD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
RAD is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
RAD is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
RAD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more RAD due diligence checks available for Premium users.
Be the first to know about important RAD news, forecast changes, insider trades & much more!
RAD News
Valuation
RAD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.15x
Industry
-9.01x
Market
22.37x
RAD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.36x
Industry
1.44x
RAD's financial health
Profit margin
Revenue
$6.1B
Net Income
-$67.1M
Profit Margin
-1.1%
RAD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
RAD's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.2B
Liabilities
$8.6B
Debt to equity
-21.34
RAD's short-term assets ($3.68B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
RAD's long-term liabilities ($5.79B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
RAD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
RAD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$132.6M
Investing
-$40.0M
Financing
-$36.4M
RAD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
RAD vs Pharmaceutical Retailer Stocks
Rite Aid Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.